نتائج البحث - "• glycoprotein IIb/ IIIa inhibitors"

المساهمون: Barbato, Emanuele, Mehilli, Julinda, Sibbing, Dirk, Siontis, George C M, Collet, Jean-Philippe, Thiele, Holger, University of Naples Federico II, Ludwig-Maximilians-Universität München (LMU), Bern University Hospital [Berne] (Inselspital), Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Institute of cardiometabolism and nutrition (ICAN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut de cardiologie [CHU Pitié-Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), University Hospital Leipzig

المصدر: European Heart Journal
European Heart Journal, Oxford University Press (OUP): Policy B, 2020, ⟨10.1093/eurheartj/ehaa601⟩

مصطلحات موضوعية: High-sensitivity troponin, Ticagrelor, Prasugrel, Chest pain unit, Platelet inhibition, medicine.medical_treatment, [SDV]Life Sciences [q-bio], Atherothrombosis, 030204 cardiovascular system & hematology, Recommendations, Guideline, Myocardial ischaemia, Diabete, Nitrate, Early invasive strategy, 0302 clinical medicine, Rivaroxaban, Clinical cases, Stent, ST segment, Apixaban, 030212 general & internal medicine, Myocardial infarction, ComputingMilieux_MISCELLANEOUS, Betablockers, MINOCA, Clinical case, Glycoprotein IIb/IIIa inhibitors, ST elevation, Diabetes, Atherothrombosi, Cangrelor, Acute cardiac care, 3. Good health, Clopidogrel, Dabigatran, Betablocker, Dual antithrombotic therapy, Cardiology, Drug Therapy, Combination, Cardiology and Cardiovascular Medicine, medicine.drug, Acute coronary syndrome, medicine.medical_specialty, Revascularisation, Glycoprotein IIb/IIIa inhibitor, Platelet Glycoprotein GPIIb-IIIa Complex, Guidelines, Revascularization, European Society of Cardiology, 03 medical and health sciences, Anticoagulation, Fibrinolytic Agents, Internal medicine, medicine, Antiplatelet, Humans, Enoxaparin, Acute Coronary Syndrome, Triple therapy, Bypass surgery, Rhythm monitoring, Nitrates, Aspirin, business.industry, Unstable angina, Heparin, Angioplasty, Bleeding, Anticoagulants, Recommendation, medicine.disease, Fondaparinux, Bleedings, Non-ST-elevation myocardial infarction, business, Edoxaban, Bivalirudin, Platelet Aggregation Inhibitors

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66fd6941baf6e23dbca457436e0a6d30Test
https://pubmed.ncbi.nlm.nih.gov/32860046Test

4

دورية أكاديمية

Biosensors for Brain Trauma and Dual Laser Doppler Flowmetry: Enoxaparin Simultaneously Reduces Stroke-Induced Dopamine and Blood Flow while Enhancing Serotonin and Blood Flow in Motor Neurons of Brain, In Vivo

المؤلفون: Patricia A. Broderick, Edwin H. Kolodny

المصدر: Sensors; Volume 11; Issue 1; Pages: 138-161

وصف الملف: application/pdf

العلاقة: Biosensors; https://dx.doi.org/10.3390/s11010013Test

الإتاحة: https://doi.org/10.3390/s11010013Test

View record in BASE

5

Comparison of heparin, bivalirudin, and different glycoprotein IIb/IIIa inhibitor regimens for anticoagulation during percutaneous coronary intervention: A network meta-analysis

المؤلفون: Michael J. Lipinski, Michael A. Gaglia, Lowell F. Satler, Ron Waksman, Rebecca Torguson, Regina C. Lee, Augusto D. Pichard, Hector M. Garcia-Garcia

المصدر: Cardiovascular Revascularization Medicine. 17:535-545

مصطلحات موضوعية: Male, Acute coronary syndrome, medicine.medical_specialty, Time Factors, Myocardial Infarction, Hemorrhage, Platelet Glycoprotein GPIIb-IIIa Complex, 030204 cardiovascular system & hematology, Risk Assessment, 03 medical and health sciences, Percutaneous Coronary Intervention, 0302 clinical medicine, Risk Factors, Internal medicine, medicine, Abciximab, Humans, Bivalirudin, Blood Transfusion, 030212 general & internal medicine, Aged, Heparin, business.industry, Coronary Thrombosis, Anticoagulants, Bayes Theorem, General Medicine, Tirofiban, Hirudins, Middle Aged, medicine.disease, Clopidogrel, Thrombocytopenia, Peptide Fragments, Recombinant Proteins, Treatment Outcome, Glycoprotein IIb/IIIa inhibitors, Eptifibatide, Cardiology, Drug Therapy, Combination, Female, Cardiology and Cardiovascular Medicine, business, Glycoprotein IIb/IIIa, Platelet Aggregation Inhibitors, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7000b7869c25305e0cc0735719e3131eTest
https://doi.org/10.1016/j.carrev.2016.09.011Test

6

Impact of time to treatment on the effects of bivalirudin vs. glycoprotein IIb/IIIa inhibitors and heparin in patients undergoing primary percutaneous coronary intervention: insights from the HORIZONS-AMI trial

المؤلفون: Girma Minalu Ayele, Gregg W. Stone, Mikkel Malby Schoos, Peter Clemmensen, Giuseppe De Luca, George Dangas, Roxana Mehran

المصدر: Schoos, M, De Luca, G, Dangas, G D, Clemmensen, P, Ayele, G M, Mehran, R & Stone, G W 2016, ' Impact of time to treatment on the effects of bivalirudin vs. glycoprotein IIb/IIIa inhibitors and heparin in patients undergoing primary percutaneous coronary intervention : insights from the HORIZONS-AMI trial ', EuroIntervention, vol. 12, no. 9, pp. 1144-1153 . https://doi.org/10.4244/EIJV12I9A186Test

مصطلحات موضوعية: Male, medicine.medical_treatment, Myocardial Infarction, Reperfusion time, 030204 cardiovascular system & hematology, Percutaneous coronary intervention, law.invention, Postoperative Complications, 0302 clinical medicine, Randomized controlled trial, Recurrence, law, Cause of Death, Myocardial Revascularization, Bivalirudin, 030212 general & internal medicine, Graft Occlusion, Vascular, Heparin, Hirudins, Middle Aged, Recombinant Proteins, Stroke, Treatment Outcome, Cardiology, Drug Therapy, Combination, Female, Cardiology and Cardiovascular Medicine, medicine.drug, medicine.medical_specialty, Platelet Glycoprotein GPIIb-IIIa Complex, Antithrombins, Time-to-Treatment, 03 medical and health sciences, Percutaneous Coronary Intervention, Internal medicine, medicine, Humans, cardiovascular diseases, Mortality, Aged, business.industry, Anticoagulants, Thrombosis, Peptide Fragments, ST-segment elevation myocardial infarction, Regimen, Glycoprotein IIb/IIIa inhibitors, Conventional PCI, ST Elevation Myocardial Infarction, business, Mace